WO2002069944A3 - Nouvelles compositions medicamenteuses a base d'anticholinergiques et d'antagonistes de recepteurs nk1 - Google Patents
Nouvelles compositions medicamenteuses a base d'anticholinergiques et d'antagonistes de recepteurs nk1 Download PDFInfo
- Publication number
- WO2002069944A3 WO2002069944A3 PCT/EP2002/001987 EP0201987W WO02069944A3 WO 2002069944 A3 WO2002069944 A3 WO 2002069944A3 EP 0201987 W EP0201987 W EP 0201987W WO 02069944 A3 WO02069944 A3 WO 02069944A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- anticholinergics
- receptor antagonists
- compositions based
- medicament compositions
- novel medicament
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MXPA03008051A MXPA03008051A (es) | 2001-03-08 | 2002-02-22 | Nuevas composiciones farmaceuticas a base de anticolinergicos y/o antagonistas del receptor nk1. |
EP02719915A EP1370293A2 (fr) | 2001-03-08 | 2002-02-26 | Nouvelles compositions medicamenteuses a base d'anticholinergiques et d'antagonistes de recepteurs nk1 |
JP2002569121A JP2004519484A (ja) | 2001-03-08 | 2002-02-26 | 抗コリン作動薬およびnk1−レセプタアンタゴニストに基づく新規医薬組成物 |
CA002439915A CA2439915A1 (fr) | 2001-03-08 | 2002-02-26 | Nouvelles compositions pharmaceutiques a base d'anticholinergiques et d'antagonistes de recepteurs nk1 |
AU2002251010A AU2002251010A1 (en) | 2001-03-08 | 2002-02-26 | Novel medicament compositions based on anticholinergics and on nk1 receptor antagonists |
AU2006202723A AU2006202723B2 (en) | 2001-02-23 | 2006-06-26 | Novel genes encoding novel proteolytic enzymes |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10111058A DE10111058A1 (de) | 2001-03-08 | 2001-03-08 | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten |
DE10111058.8 | 2001-03-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002069944A2 WO2002069944A2 (fr) | 2002-09-12 |
WO2002069944A3 true WO2002069944A3 (fr) | 2003-10-02 |
Family
ID=7676673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/001987 WO2002069944A2 (fr) | 2001-02-23 | 2002-02-26 | Nouvelles compositions medicamenteuses a base d'anticholinergiques et d'antagonistes de recepteurs nk1 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1370293A2 (fr) |
JP (1) | JP2004519484A (fr) |
AU (1) | AU2002251010A1 (fr) |
CA (1) | CA2439915A1 (fr) |
DE (1) | DE10111058A1 (fr) |
MX (1) | MXPA03008051A (fr) |
WO (1) | WO2002069944A2 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10214264A1 (de) * | 2002-03-28 | 2003-10-16 | Boehringer Ingelheim Pharma | HFA-Suspensionsformulierungen eines Anhydrats |
US7244415B2 (en) | 2002-03-28 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | HFA suspension formulations of an anhydrate |
DE10230750A1 (de) * | 2002-07-09 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittelkompositionen auf der Basis neuer Anticholonergika und NK1-Rezeptor-Antagonisten |
WO2005004875A1 (fr) * | 2003-07-14 | 2005-01-20 | Sankyo Company, Limited | Composition medicinale a administration pulmonaire |
JP2006160639A (ja) * | 2004-12-06 | 2006-06-22 | Sankyo Co Ltd | ニューロキニン受容体拮抗剤と抗コリン剤の併用 |
ITRM20120331A1 (it) * | 2012-07-12 | 2014-01-13 | Guidotti & C Spa Labor | Composizioni pediatriche orali liquide contenenti nepadutant. |
WO2015111627A1 (fr) * | 2014-01-21 | 2015-07-30 | 味の素株式会社 | Acide aminé de sucre et application associée |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0581167A1 (fr) * | 1992-07-27 | 1994-02-02 | Kyorin Pharmaceutical Co., Ltd. | Dérivés de arylglycinamide, leur procédé de préparation et leur usage pour le traitement de la dysurie |
US5545617A (en) * | 1993-11-12 | 1996-08-13 | The Schepens Eye Research Institute, Inc. | Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion |
WO1997032865A1 (fr) * | 1996-03-06 | 1997-09-12 | Boehringer Ingelheim Pharma Kg | Nouveaux derives d'arylglycinamide, leur procede de fabrication et compositions pharmaceutiques contenant ces composes |
WO1999064010A1 (fr) * | 1998-06-11 | 1999-12-16 | Merck Sharp & Dohme Limited | Utilisation d'un antagoniste du recepteur nk-1 dans le traitement des troubles psychiatriques |
US6124319A (en) * | 1997-01-21 | 2000-09-26 | Merck & Co., Inc. | 3,3-disubstituted piperidines as modulators of chemokine receptor activity |
-
2001
- 2001-03-08 DE DE10111058A patent/DE10111058A1/de not_active Withdrawn
-
2002
- 2002-02-22 MX MXPA03008051A patent/MXPA03008051A/es not_active Application Discontinuation
- 2002-02-26 JP JP2002569121A patent/JP2004519484A/ja active Pending
- 2002-02-26 EP EP02719915A patent/EP1370293A2/fr not_active Withdrawn
- 2002-02-26 CA CA002439915A patent/CA2439915A1/fr not_active Abandoned
- 2002-02-26 AU AU2002251010A patent/AU2002251010A1/en not_active Abandoned
- 2002-02-26 WO PCT/EP2002/001987 patent/WO2002069944A2/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0581167A1 (fr) * | 1992-07-27 | 1994-02-02 | Kyorin Pharmaceutical Co., Ltd. | Dérivés de arylglycinamide, leur procédé de préparation et leur usage pour le traitement de la dysurie |
US5545617A (en) * | 1993-11-12 | 1996-08-13 | The Schepens Eye Research Institute, Inc. | Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion |
WO1997032865A1 (fr) * | 1996-03-06 | 1997-09-12 | Boehringer Ingelheim Pharma Kg | Nouveaux derives d'arylglycinamide, leur procede de fabrication et compositions pharmaceutiques contenant ces composes |
US6124319A (en) * | 1997-01-21 | 2000-09-26 | Merck & Co., Inc. | 3,3-disubstituted piperidines as modulators of chemokine receptor activity |
WO1999064010A1 (fr) * | 1998-06-11 | 1999-12-16 | Merck Sharp & Dohme Limited | Utilisation d'un antagoniste du recepteur nk-1 dans le traitement des troubles psychiatriques |
Also Published As
Publication number | Publication date |
---|---|
JP2004519484A (ja) | 2004-07-02 |
WO2002069944A2 (fr) | 2002-09-12 |
EP1370293A2 (fr) | 2003-12-17 |
DE10111058A1 (de) | 2002-09-12 |
MXPA03008051A (es) | 2003-12-04 |
AU2002251010A1 (en) | 2002-09-19 |
CA2439915A1 (fr) | 2002-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU71901A (sh) | NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA | |
WO2003084539A3 (fr) | Nouvelles compositions pharmaceutiques a base d'anticholinergiques et d'inhibiteurs de la kinase p38 | |
WO2002069945A3 (fr) | Nouvelles preparations de medicaments a base d'anticholinergiques et d'inhibiteurs pde-iv | |
WO2002047668A3 (fr) | Nouvelles compositions medicamenteuses a base d'anticholinergiques et de ciclesonide | |
TW200621765A (en) | Substituted phenylaminothiazoles and their use | |
SG167657A1 (en) | Novel medicament compositions based on tiotropium salts and on salmeterol salts | |
WO2004071529A3 (fr) | Utilisations d'anticorps contre le recepteur de facteur de croissance insulinoide i | |
IL164108A (en) | Quinoline derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of medicaments for the treatment of cns and other disorders | |
WO2003000241A3 (fr) | Nouvelles compositions de medicament a base d'anticholinergiques, de corticosteroides et d'agents beta-mimetiques | |
WO2003096990A3 (fr) | Cages proteiques pour l'administration d'agents therapeutiques et d'imagerie medicale | |
AU2003289888A1 (en) | Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders | |
CA2436540A1 (fr) | Composition pharmaceutique a base d'anticholinergiques et de corticosteroides | |
WO2002088100A3 (fr) | 3-piperidinopropiophenones dopees et produits pharmaceutiques contenant ces composes | |
WO2003087049A3 (fr) | Combinaisons de produits pharmaceutiques contenant des composes heterocycliques et un nouvel anticholinergique | |
WO2003039539A3 (fr) | Utilisation d'antagonistes du recepteur de l'endotheline dans le traitement de maladies tumorales | |
WO2006015970A3 (fr) | Medicaments pour la prevention ou le traitement de la pneumonie alveolaire comprenant un anticholinergique | |
EP1262197A3 (fr) | Combinaison thérapeutique pour traiter les troubles du sommeil, y compris l'apnée du sommeil | |
WO2002069944A3 (fr) | Nouvelles compositions medicamenteuses a base d'anticholinergiques et d'antagonistes de recepteurs nk1 | |
WO2005094798A3 (fr) | Compositions pharmaceutiques a base d'anticholinergiques et d'antagonistes du recepteur ccr2 | |
TWI347845B (en) | Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same | |
WO2005123113A3 (fr) | Compositions d'interferons et leurs methodes d'utilisation | |
WO2002074034A3 (fr) | Nouvelles compositions medicamenteuses a base d'anticholinergiques et d'antagonistes de l'endotheline | |
WO2000076500A3 (fr) | Compound for use as a medicament for treatment of disorders involving bronchocontraction | |
AU2003245989A1 (en) | Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases | |
WO2004105759A3 (fr) | Nouvelles combinaisons medicamenteuses a action prolongee utilisees pour traiter des maladies des voies respiratoires |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002719915 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2439915 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2003/008051 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002569121 Country of ref document: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002719915 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |